Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
This content is for Standard 1 Year members only. LoginJoin Now